Novartis(GB:0K9E)
$160.790.00 (0.00%)
GB:0K9E
Novartis financials statements
$160.79
At close:0.00 (0.00%)
Novartis (0K9E) Income Statement
1 Followers
Novartis Income Statement
Last quarter (Q3 2026), Novartis's total revenue was $15.03B, an increase of 4.67% from the same quarter last year. In Q3, Novartis's net income was $1.20B. See Novartis’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 54.81B | $ 51.72B | $ 46.66B | $ 43.46B | $ 43.97B | |
| $ 41.12B | $ 38.90B | $ 34.19B | $ 31.88B | $ 32.24B | |
| $ 24.05B | $ 24.35B | $ 24.42B | $ 23.93B | $ 22.18B | |
| Depreciation and Amortization | $ 5.35B | $ 6.07B | $ 8.28B | $ 6.71B | $ 5.60B |
| $ 22.99B | $ 20.71B | $ 18.25B | $ 14.68B | $ 30.91B | |
| $ 17.07B | $ 14.54B | $ 9.77B | $ 7.95B | $ 10.06B | |
| $ -638.25M | $ -904.00M | $ -646.00M | $ -769.00M | $ 14.47B | |
| $ 16.44B | $ 13.64B | $ 9.12B | $ 7.18B | $ 24.53B | |
| $ 14.06B | $ 11.94B | $ 14.85B | $ 6.96B | $ 24.02B | |
| Per Share Metrics | |||||
| Basic EPS | $ 7.25 | $ 5.92 | $ 7.15 | $ 3.19 | $ 10.71 |
| Diluted EPS | $ 7.19 | $ 5.87 | $ 7.10 | $ 3.17 | $ 10.63 |
| Weighted Average Shares Outstanding | 1.94B | 2.02B | 2.08B | 2.18B | 2.24B |
| Weighted Average Shares Outstanding (Diluted) | 1.96B | 2.04B | 2.09B | 2.20B | 2.26B |
Currency in USD
